HOME >> BIOLOGY >> NEWS
Middle-aged women who consume many fruits and vegetables are at much lower risk of cardiovascular disease

Significant reductions in cardiovascular disease (CVD) risk - by as much as one-half in some cases - can be achieved by consumption of a diet high in fruits and vegetables, according to a study published in the current issue of The American Journal of Clinical Nutrition. Liu et al. assessed a large group of middle-aged female health professionals for fruit and vegetable intake and subsequently followed them over a 5-year period for instances of CVD. They found that those women who consumed the largest amounts of fruits and vegetables (10 or more servings per day) attained a correspondingly greater reduction in disease risk. When the dietary analysis excluded women with a history of high risk conditions such as diabetes, hypertension and hypercholesterolemia, risk reduction was even more pronounced. Across all of the more elevated levels of fruit and vegetable consumption - anywhere from 4 to 10 servings per day - overall reduction in CVD risk was approximately 20-30%. An editorial accompanying the study suggests that plant foods may be beneficial in human disease not only because of the nutrients they contain, but because of inherent substances that help regulate plant metabolism.

The authors analyzed prospective data from the Women's Health Study of 39,876 middle-aged nurses with no previous history of CVD. In 1993 the participants completed a detailed food-frequency questionnaire and were subsequently followed for an average of 5 years for incidence of nonfatal myocardial infarction, stroke, coronary angioplasty, coronary bypass or death due to CVD. After the researchers divided the participants into groups or levels according to the number of daily servings of fruits and vegetables, a strong inverse association was evident between total fruit and vegetable intake and relative risk of CVD. Those who consumed 10 or more servings per day were at 32% lower risk of CVD than those who consumed one serving. The overall observed CVD risk in those women who ate
'"/>

Contact: Beth Wettergreen
bmwettergreen@ucdavis.edu
530-754-7528
American Journal of Clinical Nutrition
19-Sep-2000


Page: 1 2

Related biology news :

1. Far more men than women favor routine paternity testing at birth
2. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
3. Alcohol-use and depression among pregnant and postpartum women
4. More aggressive breast cancer tumors found in African American women
5. New study confirms process leading to disorder causing male characteristics in women
6. Gestational diabetes not found to alter the metabolic processes in obese pregnant women
7. Why lung cancer in women is different from men
8. With fat, women have a more visceral response
9. NASA-inspired technology may help preserve womens future fertility after cancer treatment
10. New research finds summer-born women have fewer children
11. New studies show Curves Program raises metabolic rate in overweight and sedentary women

Post Your Comments:
(Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, ... devices with specialties in single use solutions, headquartered in ... MedConx, Inc. (a California corporation with ... San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility in ...
(Date:6/24/2015)... , June 24, 2015 The biologics ... The major drivers for the market include growth of ... of new drug launches. Over the years, the number ... Between 2001 and 2010, the FDA approved 225 drug ... to WIPO, Europe accounted for ...
(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
(Date:6/29/2015)... , ... June 29, 2015 , ... ... CAGR of around 19% during the forecast period (2015 to 2020). The market ... upsurge in government and corporate funding for R&D. However, lack of adequate healthcare ...
(Date:6/29/2015)... -- Neuralstem, Inc. (NYSE MKT: CUR), a biopharmaceutical company using ... cell therapy treatments for central nervous system diseases, announced ... the NASDAQ Capital Market under the symbol "CUR." The ... NYSE MKT until the market close on July 10, ... to commence on July 13, 2015. ...
(Date:6/29/2015)... June 29, 2015   For the seventh year running, ... assess their overall digital maturity called the Multichannel ... companies are not maturing fast enough. While it,s true ... numerous ways overall and customers are increasingly "digital natives", ... digital customer engagement.  ...
(Date:6/26/2015)... 26, 2015 /PRNewswire/ - iCo Therapeutics ("iCo" or "the ... all nominees listed in the management information circular ... 2015 Annual Meeting of Shareholders, held earlier today, ... the following 5 nominees proposed by management were ... until the Company,s next Annual Meeting of Shareholders ...
Breaking Biology Technology:Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 2Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 3Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 4Microfluidics Market Growing at 19.3% CAGR To 2020 – New research available at ReportsnReports.com 5Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 2Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market 3Results from Digital Maturity Study Show Pharma Lagging 2Results from Digital Maturity Study Show Pharma Lagging 3Results from Digital Maturity Study Show Pharma Lagging 4iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 2iCo Therapeutics Announces Voting & Election Results from Annual Meeting of Shareholders 3
Cached News: